GLYCOREX TRANSPLANTATION
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, enables transplants across the blood group boundaries. This product has been used clinically since the fall of 2001 and enabled more than 3,500 blood group incompatible transplants with excellent clinical results. The company also develops products within universal blood plasma and products for specific treatment of autoimmune diseases, specifically Myasthenia gravis.
GLYCOREX TRANSPLANTATION
Industry:
Biotechnology Clinical Trials Health Care Manufacturing Medical Pharmaceutical
Founded:
1996-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.glycorex.se
Total Employee:
11+
Status:
Active
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Cision
Similar Organizations
Body Surface Translations
Body Surface Translations is a biomedical device company.
Promedim
Promedim is advanced cloud-based technology, integrated control centre.
Current Employees Featured
Kurt Nilsson Founder @ Glycorex Transplantation
Founder
Johan Nilsson CEO @ Glycorex Transplantation
CEO
2013-09-01
Founder
Official Site Inspections
http://www.glycorex.se
- Host name: akilles.oderland.com
- IP address: 91.201.60.23
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Glycorex Transplantation"
Home - Glycorex Transplantation AB
Glycorex’s unique molecular level technology that specifically selects and removes antibodies in the blood has opened up revolutionary treatments and ... Scheelevägen 27 | SE-223 63 Lund, …See details»
Board of Directors and CEO - Glycorex …
Mar 29, 2021 Background and education: Founder and former CEO and Development and Product Manager at Glycorex …See details»
Corporate Governance - Glycorex Transplantation AB
Mar 29, 2021 +46 46 286 52 30 info@glycorex.com. About Glycorex. Market strategy; Investors. Financial reports; The Share – information; Presentations; Corporate Governance; Board of …See details»
Glycorex Transplantation AB - A Company At Ideon
Glycorex Transplantation AB (publ) is a medical technology company involved in development, production and sales in the fields of organ transplantation and. Stories & News; ...See details»
Glycorex AB - A Company At Ideon - Ideon Science Park
Glycorex AB. Address. Scheelevägen 27, 223 70 Lund. Building. Gateway. Company website. www.glycorex.se. Phone. 046-286 5230. E-mail. glycorex@glycorex.ideon.se. About Ideon. …See details»
Glycorex Transplantation - Crunchbase Company …
Glycorex Transplantation AB (publ) is a medical technology company that conducts research, development, production and sales, especially in the field of organ transplantation. The company's main product, Glycosorb ® -ABO, …See details»
Glycorex Aktiebolag - Företagsinformation - allabolag.se
Glycorex Aktiebolag,556420-0235 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Glycorex Aktiebolag Sök Få mer …See details»
Glycorex Transplantation AB - ngm.se
Glycorex Transplantation är ett bioteknikbolag. Idag bedriver bolaget forskning, utveckling och marknadsföring inom området för organtransplantation. Bolagets huvudprodukt Glycosorb …See details»
Glycorex Transplantation AB (publ) - Företagsinformation
Glycorex Transplantation AB (publ),556519-7372 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Glycorex Transplantation …See details»
Glycorex Transplantation AB (publ) - LinkedIn
Glycorex Transplantation AB (publ) is a globally recognized medical technology company headquartered in Lund, Sweden, with a unique know-how in the fields of biologically active …See details»
About Glycorex - Glycorex Transplantation AB
Glycorex has recently launched a new product version designed to be used for donated plasma to produce universal blood plasma that can be given regardless of the recipient’s blood group, …See details»
Glycorex Aktiebolag - 556420-0235 - Trelleborg - Se Nyckeltal ...
Allabolag.se ger dig företagsinformation om Glycorex Aktiebolag, 556420-0235. Hitta adress på karta, kontaktinfo, nyckeltal och befattningar.See details»
Glycorex AB - Företagsinformation | hitta.se
Glycorex AB (556420-0235). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.See details»
Glycorex Transplantation AB | Nordic Growth Market - ngm.se
Glycorex Transplantation is a biotechnology company. Currently, the company conducts research, development and marketing within the field of organ transplantation. The main product of the …See details»
Oenighet i transplantationsbolag – vd och styrelse hoppar av
Oct 16, 2023 Glycorex har utvecklat en medicinteknisk produkt för att möjliggöra organtransplantationer över blodgruppsgränserna. Den används framförallt vid …See details»
Glycorex stärker organisationen för att lägga ytterligare kraft …
Jan 31, 2023 Den 8 december 2022 tillträdde Johan Lavén som ny vd på Glycorex med uppdrag att genomföra bolagets tillväxtstrategi genom att expandera bolagets verksamhet inom …See details»
Om Glycorex - Glycorex Transplantation AB
Glycorex har nyligen lanserat en lösning för behandling av blodgivarblod som innebär att all blodplasma som produceras vid blodgivarcentraler kan ges till samtliga patienter – oavsett …See details»
Glycorex Transplantation - placera.se
Dec 21, 2021 E-mail: info@glycorex.se, phone: 046-286 52 30 Brief information about the company Glycosorb® ABO is one of Glycorex Transplantation AB's self-developed proprietary …See details»
Glycorex Transplantation - Cision News
Glycorex är ett globalt medicintekniskt bolag grundat 1996 med huvudkontor i Lund, Sverige. Bolaget har en unik kunskap inom biologiskt aktiva kolhydrater och extrakorporeala …See details»
Enabling transplants across blood groups is no longer science fiction
CEO Geert Nygaard joined Glycorex in December 2021. Since then, he has worked together with his team to define the way forward for the company. In this interview, Geert talks about …See details»